Relevare Pharmaceuticals

Relevare Pharmaceuticals is developing therapies to treat long-lasting or often-caused pains in the human body.

Relevare Pharmaceuticals LTD., a specialty pharmaceutical company, develops therapies to treat chronic and acute pain in Australia. It develops CNSB015 and CNSB001, a fixed dose combination therapy for neuropathic pain; CNSB002, a sodium channel antagonist with antioxidant properties for the treatment of inflammatory and neuropathic pain; CNSB004, an N-type calcium channel antagonist for the treatment of severe pain; and CNSB006 and CNSB007, a therapy for inflammatory and neuropathic pain. Relevare Pharmaceuticals LTD. was formerly known as CNSBio Pty Ltd. and changed its name to Relevare Pharmaceuticals LTD. in April 2010. The company was founded in 2003 and is based in Abbotsford, Australia.